Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT03504709
The aim of this study is to assess the utility of advanced magnetic resonance imaging (MRI) and electroencephalographic (EEG) technologies for predicting functional outcomes in patients with severe traumatic brain injury (TBI).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients:
Inclusion criteria
Exclusion criteria
Healthy Subjects:
Exclusion criteria
History of brain injury or neurological disease, psychiatric disease, or any history of diabetes, high blood pressure, heart disease, or kidney disease
Time frame: 6 months post injury
The Disability Rating Scale (DRS) provides quantitative information regarding functional disability in patients recovering from severe brain injury. The total score on the DRS ranges from 0 to 29 with higher scores indicating a greater degree of disability. DRS subscale scores include eye opening [score range 0-3], communication [score range 0-4], motor response [score range 0-5], cognitive ability for feeding [score range 0-3], cognitive ability for toileting [score range 0-3], cognitive ability for grooming [score range 0-3], level of function [score range 0-5], and employability [score range 0-3]. Subscale scores are summed to produce the total score.
Massachusetts General Hospital
Other
Advanced MRI and EEG to Predict Recovery of Consciousness After Severe Traumatic Brain Injury
Acronym: RESPONSE 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04476589
COVID-19, Coma
Boston, Massachusetts, United States
View Trial DetailsNCT04534777
Brain Damage, Chronic, Brain Diseases
Paris, France
View Trial DetailsNCT04065386
Brain Damage, Chronic, Brain Diseases
Ottignies-Louvain-la-Neuve, Brabant Wallon, Belgium
View Trial DetailsNCT05367999
Brain Diseases, Central Nervous System Diseases
Sheffield, South Yorkshire, United Kingdom
View Trial Details